CSIS Examines Polio Eradication in India and Public-Private Partnerships in Zambia
GHC member the Center for Strategic and International Studies (CSIS) Global Health Policy Center recently led two separate delegations to India and Zambia to look at key health challenges facing the two nations. The first delegation, consisting of Congressional staff, examined India’s use of tools to increase broader immunization rates, enhance disease surveillance, and improve health communications in underserved areas in an effort towards global polio eradication. In Zambia, the CSIS Task Force on Women’s and Family Health surveyed several public-private partnerships focused on advancing women’s health. Read more on their findings in India and Zambia.
NIH Begins Zika Vaccine Trial
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, recently launched a clinical trial of a vaccine candidate intended to prevent Zika virus infection. The early-stage study will evaluate the experimental vaccine’s safety and ability to generate an immune system response in participants. At least 80 healthy volunteers ages 18-35 years at three study sites in the U.S., are expected to participate in the trial. The study is part of the U.S. government response to the ongoing outbreak of Zika virus in the Americas. Over 6,400 Zika cases have been reported in the U.S. and its territories. Read more about the clinical trial.
PATH Launches Malaria Learning Series
Last week, PATH launched the Malaria Learning Series; a collection of reports on the latest evidence in malaria research in a format accessible to policymakers and donors. The first of the series “Population-Wide Drug-Based Strategies for Malaria Elimination” discusses PATH’s work in partnership with national malaria programs and others to evaluate the impact, operational requirements, and costs of population-wide drug-based strategies in Ethiopia, Senegal, and Zambia. Findings indicate that these strategies, which generally require reaching large populations across wide geographic areas, are operationally feasible. Follow the series.
UN High Level Meeting on Antimicrobial Resistance
On September 21, the UN General Assembly will host a High-level Meeting at UN Headquarters in New York on antimicrobial resistance. The objectives of the meeting are to increase awareness of the issue; to summon and maintain strong national, regional, and international political commitment; and to establish a long-term basis for moving forward in addressing antimicrobial resistance comprehensively and multi-sectorally. There is an open process for stakeholders, including civil society, academia, philanthropy, and the private sector, to apply to attend the meeting. Application deadlines are August 15 and August 28. Apply for the meeting.